Average Co-Inventor Count = 2.22
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alkermes Pharma Ireland Limited (10 from 160 patents)
2. Civitas Therapeutics, Inc. (3 from 30 patents)
3. Alkermes, Inc. (1 from 75 patents)
14 patents:
1. 10806731 - Compositions of buprenorphine and μ antagonists
2. 10758527 - Opioid agonist antagonist combinations
3. 10314838 - Compositions of buprenorphine and μ antagonists
4. 10195191 - Opioid agonist antagonist combinations
5. 10188643 - Compositions of buprenorphine and μ antagonists
6. 9918978 - Compositions of buprenorphine and μ antagonists
7. 9913837 - Compositions of buprenorphine and μ antagonists
8. 9498474 - Compositions of buprenorphine and μ Antagonists
9. 9211293 - Opioid agonist antagonist combinations
10. 8822488 - Compositions of buprenorphine and μ antagonists
11. 8747813 - Inhalable epinephrine
12. 8415397 - Inhalable epinephrine
13. 7947742 - Inhalable epinephrine
14. 7919499 - Naltrexone long acting formulations and methods of use